THYROCARENSEThyrocare Technologies LimitedMediumNeutral
Announced Tue, 30 Jun · 20:31 IST

26th AGM held on June 30 2026; all 10 resolutions passed, final dividend Rs 7 declared

Board & Shareholder Meetings View source PDF

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹549.20
prior close
₹554.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3-0.4-0.6-1.5+1.4+0.9-1.1-3.1-4.6-6.1+1.6
Up moveDown movePending
AI summary

Thyrocare held its 26th AGM on June 30, 2026. 66 shareholders attended, representing 61.10% of paid-up capital. All 10 resolutions were passed with requisite majority. Key items: final dividend of Rs 7 per share on top of Rs 7 interim (pre-bonus), adoption of FY26 results with consolidated revenue of Rs 829.04 Cr (up 21%) and profit of Rs 162.85 Cr (up 79%), appointment of Price Waterhouse as new statutory auditors for 5 years, re-appointment of MD and CEO Rahul Franklin Guha from May 4, 2027, and approval for material related party transactions with Docon Technologies.

Likely market impact

Strong FY26 results: revenue up 21% and profit up 79% year-on-year. Final dividend of Rs 7 declared. New auditor and MD re-appointment approved. No negative votes of concern.